Prominent molecular features of NEPC/small cell carcinoma include loss of RB1 and TP53, low or absent AR and AR pathway outputs, and induction of SOX2 and the epigenetic enzymes EZH2 and DNMT1. The gene discussed is AR; the disease is small cell carcinoma.